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CT also showed bone lesions of the calvarium. A whole-body
bone scan (Fig. 3) was  performed.
Question 3: Interpret Fig. 3. What treatment do you propose?. Case report
A 55 year-old man  presented in emergency with grade IV right
eripheral facial palsy on the House and Brackmann classiﬁcation,
nd poorly systematized right semicranial pain of sudden onset
 weeks previously, managed by corticotherapy (Prednisolone
 mg/kg/day (i.e., 80 mg)  for 5 days) as idiopathic facial palsy. There
ere no signs of cochleovestibular involvement. He had a history of
moking (80 pack-years). Initial pure-tone and speech audiometry
ound no hearing loss; impedancemetry found conserved stapedial
eﬂex. Given the painful and non-regressive nature of the palsy,
emporal bone CT was performed (Fig. 1A) and found a lytic image.
emporal bone MRI  (Fig. 1B and C) was requested to specify the
ature of the lesion.
DOI of original article: http://dx.doi.org/10.1016/j.aforl.2014.02.008.
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Question 1: Interpret Fig. 1.
As part of extension assessment, contrast-enhanced cerebral,
thoracic, abdominal and pelvic CT (Fig. 2) was  requested.
Question 2: Interpret Fig. 2. How do you conﬁrm the pathology
diagnosis?
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Fig. 1. Right temporal bone CT, axial slices (A); axial T1-weighted cerebral MRI without gadolinium injection, through the temporal bone (B); axial T1-weighted cerebral
MRI  with gadolinium injection, through the temporal bone (C).
Fig. 2. Parenchymatous-window thoracic CT, axial slices, with contrast medium
injection.
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Fig. 3. Whole-body technetium-99 bone scan.
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.1. Reply 1
Fig. 1A is a right temporal bone axial slice CT scan without con-
rast injection. It shows mastoid cell involvement by a lytic lesion
arrow), with a crumbly aspect to internal table of the temporal
one. The lesion contacts the sigmoid sinus at the jugular foramen,
hich it enlarges, affecting the mastoid part of the facial nerve.
Fig. 1B is a cranioencephalic MRI  axial T1-weighted acquisi-
ion without contrast enhancement, through the temporal bone.
t shows a right temporal bone lesion (arrow) in tissue T1 isosignal.
Fig. 1C is an axial T1-weighted fat-sat cerebral MRI  acquisition
ith gadolinium enhancement through the temporal bone. The
esion (arrow) measures 16.23 × 26.29 mm.  There is heterogeneous
nhancement and a non-enhanced necrotic center. There is right
igmoid sinus compression.
These images suggest several possible diagnoses, and notably
etastasis to the petrous and mastoid part of the temporal bone
r endolymphatic sac tumor. Complete extension assessment is
herefore necessary before undertaking surgical biopsy.
.2. Reply 2
Fig. 2 is a contrast-enhanced parenchymatous-window thoracic
T scan, axial slice. It shows a ramiﬁed speculated tissue lesion of
he apical segment of the right superior lobe (arrow), suggesting a
resumably primary tumoral process.
The suggested diagnosis was metastasis of a primary lung tumor
o the petrous part of the right temporal bone. Assessment required
o be completed by anatomopathology.
Transmastoid biopsy was considered, but entailed a risk of sig-
oid sinus lesion, meningeal breach and aggravation of the facial
alsy by compressive intratumoral hematoma or direct lesion. After
ultidisciplinary discussion with the neurosurgery and pneumol-
gy teams, it was decided to perform CT-guided biopsy of the
rimary pulmonary lesion, as entailing less risk. Histology found
rade IV acinar adenocarcinoma.
.3. Reply 3
Fig. 3 is a whole-body technetium-99 bone scan, showing sev-
ral hyperﬁxation sites indicative of secondary bone lesions of the
alvarium, right temporal bone, right iliac wing, sacrum and tibias.
This was a T2N2M1 pulmonary adenocarcinoma, with multi-
le bone metastases. A multidisciplinary oncology team meeting
ecided on palliative care, comprising:3 cycles of cisplatin and
emetrexed (Alimta®) chemotherapy;analgesic right temporal
adiation therapy.
CT reassessment during treatment found dissociated evolution,
ith a reduced pulmonary lesion but considerably increased bone
esions.
Second-line chemotherapy with 3 cycles of docetaxel
Taxotère®) was initiated, but the patient died during the third
ycle, 6 months after onset of facial palsy.
. Comments
Idiopathic facial palsy is often considered in adult facial palsy,
ut should in fact be a diagnosis of elimination. Painful and persis-
ent facial palsy casts doubt on such a diagnosis and should lead
o temporal bone CT scan to rule out tumoral etiology. The phys-
opathology of this pain is complex: neural involvement by invasion
r compression of the sensory contingent of the facial nerve inner-
ating the Ramsey Hunt region, or of the trigeminal nerve in case oflogy, Head and Neck diseases 131 (2014) 201–205
large lesion. The bone involvement itself may  be implicated, with
release of inﬂammation mediators by metastatic cells.
In the petrous part of the temporal bone, tumors liable to
induce facial palsy are: cholesteatoma, paraganglioma, Langer-
hans cell histiocytosis, lymphoma, sarcoma, multiple myeloma
in the elderly, endolymphatic sac tumor and metastasis of solid
malignant tumor [1]. In the present case, the location, lytic CT
aspect and heterogeneous MRI  aspect with enhancement on injec-
tion might suggest malignant endolymphatic sac tumor with
pulmonary metastasis. The symptomatology, however, usually
includes cochlear and vestibular signs; moreover, although cases
of adenocarcinoma have been reported, they had a papillary rather
than acinar architecture; and ﬁnally, only one case of remote metas-
tasis is to be found in the literature [2].
The malignant solid tumors most liable to metastasize in this
region, according to Gloria-Cruz et al. [3], are mammary adeno-
carcinomas and, secondly, lung cancers. Adenocarcinoma is the
most frequent histologic form of lung cancer found in petrous bone
metastasis; others are undifferentiated carcinoma and small-cell
neuroendocrine carcinoma [4].
The petrous apex is the region of the temporal bone most
frequently involved by metastasis. Bone invasion is initially
hematogenic, from the bone marrow of the petrous apex [3],
spreading contiguously toward the mastoid. Isolated mastoid
involvement, as in the present case, is rare: only 1.3% of temporal
bone metastases in the series reported by Gloria-Cruz et al. [3].
The clinical expression of intrapetrous metastasis is polymor-
phic. Hearing loss seems to be the most frequent sign [3], followed
by peripheral facial palsy, which is rarely isolated as in the present
case. Bakhos et al. [1] reported the following symptoms in 2
patients: hearing loss, tinnitus, headache, dysphonia and retro-
auricular tumefaction. Other revelatory signs mentioned in the
literature are vertigo, otalgia, otorrhea and external auditory canal
tumefaction [3].
Tumoral involvement of the facial nerve, by compression,
inﬂammation or invasion, may  occur at any point along the tra-
jectory: in the brainstem, within the internal auditory canal, in
the labyrinthine, tympanic or mastoid intrapetrosal segment, or
at the exit from the stylomastoid foramen [4]. Facial canal invasion
does not necessarily entail peripheral facial palsy: only 6 of the 14
patients with facial canal invasion in Gloria-Cruz et al.’s series [3]
showed peripheral facial palsy (42.8%).
A lytic lesion on temporal bone CT is suggestive of a secondary
lesion, and should be followed by MRI  with T1 and T2-weighted
sequences and T1 acquisition with gadolinium injection, to specify
the lesion and its limits and explore for endocranial and meningeal
complications. In case of early clinical signs in a non-advanced
tumor, absence of bone erosion on CT and MRI  may  lead to mis-
diagnosis [3].
Histologic diagnosis is essential to treatment strategy. When
a secondary lesion is suspected, however, biopsy should be pre-
ceded by complete extension assessment. Lesions are less easily
accessible to surgery when situated in the petrous apex than in
the mastoid; in the present case, given the location, transmastoid
biopsy was  considered, but was  not carried out because the exten-
sion assessment revealed the much more accessible primary lesion
[1].
The reference examination for bone metastasis is technetium-
99 bone scan. Its speciﬁcity is, however, low as it detects
osteoblastic activity whether of malignant or benign etiology. In
case of malignancy, moreover, this activity may  persist despite a
good treatment response, making bone scan unsuited to assessing
the latter. Positron emission tomography coupled to CT (PET-CT) is
at present a great focus of interest for the detection of secondary
bone lesions [5], and seems to be dependent on primary lesion
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istology. In bronchopulmonary cancer, the two  examinations
how comparable performance, with easier lesion location on the
keleton using bone scan and better speciﬁcity with PET-CT in case
f doubt (which was not the case with the present patient). The
ther advantages of PET-CT are better image quality and the possi-
ility of also detecting other non-osseous metastases.
Intrapetrous metastasis from a solid tumor indicates an
dvanced stage [1]. When a primary tumor with a single metastasis
s operable, curative surgery at both locations is feasible. Treatment,
owever, is often in fact palliative, associating platinum-based
hemotherapy and radiation therapy focusing on the metastases
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